Skip to Content

DIA Workshop on Benefit-Risk Strategy

Start Date:
Thursday, 15 June, 2017
End Date:
Friday, 16 June, 2017 5:00pm
Speciality:
Internal Medicine
Website:
http://go.evvnt.com/131261-0

Are you aware of the key developments on the benefit-risk guidelines? Benefit-risk guidelines continue to evolve with the EMA publishing guidance revisions as recently as this March. This workshop provides you the tools to address these changes by giving you: - Overview of benefit-risk assessments- Examples of challenges and solutions across different departments- Impacts and interpretations of the new guidelines EMA experts join this workshop to give you tangible insights and tips to navigate the evolving benefit-risk guidelines.

The hands-on workshop structure provides you with real-world examples from regulatory and industry perspectives, and explores tangible ways to improve your best practices. Who should attend?Professionals involved in benefit-risk strategy from various departments, e.g. pharmacovigilance, regulatory, clinical, drug safety, medical affairs, or medical writing. Program leads who oversee the clinical development, dossier preparation, and post-marketing phases of the medicines life cycle.

Learning objectives - What will you gain? New benefit-risk regulations call for a more structured and formalised process. This workshop will: - Increase your understanding of the current benefit and risk landscape- Empower you to perform benefit-risk management more effectively within your organisation- Create a toolkit for you to address tactical components of risk assessments, including data collection and digital innovation PriceIndustry Member: EUR 1430, Industry Non-member: EUR 1585, Government/Charitable/Non-profit/Academia (Full-Time) Member: EUR 715, Government/Charitable/Non-profit/Academia (Full-Time) Non-member: USD 870 Speakers: Martin Huber PRAC Member Federal Institute for Drugs and Medical Devices (BfArM) Germany, Steve Mayall PhD Principal Consultant Pope Woodhead and Associates Ltd United Kingdom, Jan Petracek MD MSc CEO PrimeVigilance and PharmInvent Czech Republic, Steffen Thirstrup MD PhD Director NDA Advisory Services Ltd United Kingdom

Location

Grand Majestic Plaza,
Truhlrsk 16,
Prague 1,
110 00,
Czech Republic

Organizer Details

Conference organized by DIA EMEA

Phone:
41 61 225 5151
Email:
EMEA@diaglobal.org

Medical conference data provided by Meetings4Docs | Report a problem

Image Gallery

Hide